MAPT and Alzheimer disease: In mice lacking the gene encoding the IL-1 inhibitor IL-1Ra the AD-like pathology is exacerbated (52), while the IL-1R1 blockade results in decreased neuroinflammation, attenuated tau pathology and reversal of cognitive deficits (53).